Benzinga | Dec 24, 2020 06:17AM EST

HC Wainwright & Co. Reiterates Buy on Verrica Pharmaceuticals, Raises Price Target to $21

HC Wainwright & Co. reiterates Verrica Pharmaceuticals (NASDAQ:VRCA) with a Buy and raises the price target from $18 to $21.